Filing Details
- Accession Number:
- 0001209191-19-043022
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-07-24 16:12:52
- Reporting Period:
- 2019-07-22
- Accepted Time:
- 2019-07-24 16:12:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1759425 | Mirum Pharmaceuticals Inc. | MIRM | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1365617 | J Patrick Heron | C/O Frazier Healthcare Partners 70 Willow Road, Suite 200 Menlo Park CA 94025 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-07-22 | 3,116,912 | $0.00 | 3,116,912 | No | 4 | C | Indirect | By Frazier Life Sciences IX, L.P. |
| Common Stock | Acquisiton | 2019-07-22 | 450,000 | $15.00 | 3,566,912 | No | 4 | P | Indirect | By Frazier Life Sciences IX, L.P. |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Indirect | By Frazier Life Sciences IX, L.P. |
| No | 4 | P | Indirect | By Frazier Life Sciences IX, L.P. |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A Preferred Stock | Disposition | 2019-07-22 | 24,935,300 | $0.00 | 3,116,912 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Indirect |
Footnotes
- In connection with the Issuer's initial public offering, each share of the Issuer's Series A Preferred Stock automatically converted into 0.125 shares of the Issuer's Common Stock. The shares have no expiration date.
- The shares are held directly by Frazier Life Sciences IX, L.P. FHMLS IX, L.P. is the general partner of Frazier Life Sciences IX, L.P. FHMLS IX, L.L.C. is the general partner of FHMLS IX, L.P. The Reporting Person and James N. Topper are the managing members of FHMLS IX, L.L.C. and share voting and dispositive power over the shares held by Frazier Life Sciences IX, L.P. The Reporting Person disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest therein.
- The shares were purchased in the Issuer's initial public offering.
Billionaire Hedge Funds
